Publikationen pro Jahr
Publikationen pro Jahr
Publikationen
- 1 – 50 von 59 Ergebnissen
Suchergebnisse
-
2025
Neoadjuvant atezolizumab in combination with dual HER2 blockade plus epirubicin in women with early HER2-positive breast cancer: the randomized phase 2 ABCSG-52/ATHENE trial
Rinnerthaler, G. (Erstautor/-in), Egle, D., Bartsch, R., Schmitt, C. A., Petzer, A., Balic, M., Petru, E., Denison, U., Singer, C. F., Bjelic-Radisic, V., Gampenrieder, S. P. (Co-Autor/-in), Knauer, M., Sotlar, K. (Co-Autor/-in), Brunner, C. (Co-Autor/-in), Posch, F., Hlauschek, D., Sölkner, L., Bago-Horvath, Z., Filipits, M. & Gili, M. &10 mehr, , 16 Jan. 2025, in: NATURE CANCER. 13 S.Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
Open Access -
2024
Combined DNA Analysis from Stool and Blood Samples Improves Tumor Tracking and Assessment of Clonal Heterogeneity in Localized Rectal Cancer Patients
Parigger, T., Gassner, F. J. (Co-Autor/-in), Drothler, S., Scherhaeufl, C., Hoedlmoser, A., Schultheis, L., Abu Bakar, A., Huemer, F. (Co-Autor/-in), Greil, R. (Co-Autor/-in), Geisberger, R. (Co-Autor/-in), Weiss, L. (Letztautor/-in) & Zaborsky, N. (Letztautor/-in), 2024, in: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 23, 12 S., 15330338241252706.Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
Open Access -
Image-based consensus molecular subtyping in rectal cancer biopsies and response to neoadjuvant chemoradiotherapy
Lafarge, M. W., Domingo, E., Sirinukunwattana, K., Wood, R., Samuel, L., Murray, G., Richman, S. D., Blake, A., Sebag-Montefiore, D., Gollins, S., Klieser, E. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in), Huemer, F. (Co-Autor/-in), Greil, R. (Co-Autor/-in), Dunne, P., Quirke, P., Weiss, L. (Co-Autor/-in), Rittscher, J., Maughan, T. & Koelzer, V. H., 9 Apr. 2024, in: NPJ precision oncology. 8, 1, S. 89 11 S., 89.Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
Open Access -
mFOLFOX6 versus mFOLFOX6 + aflibercept as neoadjuvant treatment in MRI-defined T3-rectal cancer: a randomized phase-II-trial of the German Rectal Cancer Study Group (CAO/ARO/AIO 0214)
Hofheinz, R.-D., Herrle, F., Dechow, T., von Weikersthal, L. F., Welslau, M., Lettmaier, S., Burkart, C., Kubicka, S., Kochen, L., Merx, K., Krause, K., Ebert, M., Rödel, C., Fokas, E., Ghadimi, M., Reissfelder, C., Gaiser, T. & Weiss, L. (Study group member), Sept. 2024, in: ESMO OPEN. 9, 9, S. 103703Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
Open Access -
Prediction of survival after neoadjuvant therapy in locally advanced rectal cancer - a retrospective analysis
Piringer, G., Ponholzer, F., Thaler, J., Bachleitner-Hofmann, T., Rumpold, H., de Vries, A., Weiss, L. (Co-Autor/-in), Greil, R. (Co-Autor/-in), Gnant, M., Oefner, D. & Austrian Breast & Colorectal Cancer Study Group, 16 Mai 2024, in: FRONTIERS IN ONCOLOGY. 14, S. 1374592 10 S., 1374592.Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
Open Access1 Quellenangabe (Web of Science) -
2023
Body composition dynamics and impact on clinical outcome in gastric and gastro-esophageal junction cancer patients undergoing perioperative chemotherapy with the FLOT protocol
Huemer, F. (Erstautor/-in), Hecht, S. (Co-Autor/-in), Scharinger, B. (Co-Autor/-in), Schlintl, V., Rinnerthaler, G. (Co-Autor/-in), Schlick, K. (Co-Autor/-in), Heregger, R., Melchardt, T. (Co-Autor/-in), Wimmer, A. (Co-Autor/-in), Mühlbacher, I. (Co-Autor/-in), Koch, O. O. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in), Klieser, E. (Co-Autor/-in), Seyedinia, S., Beheshti, M. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Weiss, L. (Letztautor/-in), Juli 2023, in: JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY . 149, 7, S. 3051-3064 14 S.Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
-
Comparison of gemcitabine plus oxaliplatin versus gemcitabine plus nab-paclitaxel as first-line chemotherapy for advanced pancreatic adenocarcinoma: A single-center retrospective analysis
Schlick, K. (Erstautor/-in), Gantschnigg, A. (Co-Autor/-in), Seymer, A., Huemer, F. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Weiss, L. (Letztautor/-in), Aug. 2023, in: CANCER MEDICINE. 12, 16, S. 16997-17004 8 S.Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
Open Access2 Quellenangaben (Web of Science) -
Management of metastatic colorectal cancer in patients ≥70 years - a single center experience.
Huemer, F. (Erstautor/-in), Dunkl, C., Rinnerthaler, G. (Co-Autor/-in), Schlick, K. (Co-Autor/-in), Heregger, R. (Co-Autor/-in), Emmanuel, K. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in), Klieser, E. (Co-Autor/-in), Deutschmann, M. (Co-Autor/-in), Roeder, F. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Weiss, L. (Letztautor/-in), 25 Juli 2023, in: FRONTIERS IN ONCOLOGY. 13, S. 1222951 11 S., 1222951.Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
-
Prognostic value of [18F]FDG PET/CT on treatment response and progression-free survival of gastroesophageal cancer patients undergoing perioperative FLOT chemotherapy
Mirshahvalad, S. A., Seyedinia, S. S., Huemer, F. (Co-Autor/-in), Schweighofer-Zwink, G. (Co-Autor/-in), Koch, O. O. (Co-Autor/-in), Hitzl, W. (Co-Autor/-in), Weiss, L. (Co-Autor/-in), Emannuel, K., Greil, R. (Co-Autor/-in), Pirich, C. (Co-Autor/-in) & Beheshti, M. (Letztautor/-in), Apr. 2023, in: EUROPEAN JOURNAL OF RADIOLOGY . 163, 163 (1), S. 110843Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
2 Quellenangaben (Web of Science) -
Real-world Data of Palliative First-line Checkpoint Inhibitor Therapy for Head and Neck Cancer
Wagner, S. (Erstautor/-in), Magnes, T. (Co-Autor/-in), Melchardt, T. (Co-Autor/-in), Kiem, D. (Co-Autor/-in), Weiss, L. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in), Wagner, C., Aretin, M.-B., Nemec, S., Gamerith, G., Pall, G., Greil, R. (Co-Autor/-in) & Fuereder, T., März 2023, in: ANTICANCER RESEARCH . 43, 3, S. 1273-1282 10 S.Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
5 Quellenangaben (Web of Science) -
Systemic treatment of patients with locally advanced or metastatic cholangiocarcinoma - an Austrian expert consensus statement
Taghizadeh, H., Djanani, A., Eisterer, W., Gerger, A., Gruenberger, B., Gruenberger, T., Rumpold, H., Weiss, L. (Co-Autor/-in), Winder, T., Wöll, E. & Prager, G. W., 2023, in: FRONTIERS IN ONCOLOGY. 13, S. 1225154Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
1 Quellenangabe (Web of Science) -
2022
Checkpoint inhibitors in metastatic gastric and GEJ cancer: a multi-institutional retrospective analysis of real-world data in a Western cohort
Schlintl, V., Huemer, F. (Erstautor/-in), Rinnerthaler, G. (Co-Autor/-in), Melchardt, T. (Co-Autor/-in), Winder, T., Reimann, P., Riedl, J., Amann, A., Eisterer, W., Romeder, F., Piringer, G., Ilhan-Mutlu, A., Wöll, E., Greil, R. (Co-Autor/-in) & Weiss, L. (Letztautor/-in), 10 Jan. 2022, in: BMC CANCER. 22, 1, S. 51Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
6 Quellenangaben (Web of Science) -
The CIRCULATE Trial: Circulating Tumor DNA Based Decision for Adjuvant Treatment in Colon Cancer Stage II Evaluation (AIO-KRK-0217)
Folprecht, G., Reinacher-Schick, A., Weitz, J., Lugnier, C., Kraeft, A., Wisser, S., Aust, D., Weiss, L. (Co-Autor/-in), von Bubnoff, N., Kramer, M., Thiede, C. & Tannapfel, A., Juni 2022, in: CLINICAL COLORECTAL CANCER. 21, 2, S. 170-174 5 S.Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
20 Quellenangaben (Web of Science) -
2021
Clonal evolution in diffuse large B-cell lymphoma with central nervous system recurrence
Magnes, T. (Erstautor/-in), Wagner, S. (Co-Autor/-in), Thorner, A. R., Neureiter, D. (Co-Autor/-in), Klieser, E. (Co-Autor/-in), Rinnerthaler, G. (Co-Autor/-in), Weiss, L. (Co-Autor/-in), Huemer, F. (Co-Autor/-in), Zaborsky, N. (Co-Autor/-in), Steiner, M. (Co-Autor/-in), Weis, S., Greil, R. (Co-Autor/-in), Egle, A. (Co-Autor/-in) & Melchardt, T. (Letztautor/-in), Feb. 2021, in: ESMO OPEN. 6, 1, S. 100012Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
8 Quellenangaben (Web of Science) -
Evaluation of circulating cell-free KRAS mutational status as a molecular monitoring tool in patients with pancreatic cancer
Schlick, K. (Erstautor/-in), Markus, S., Huemer, F. (Co-Autor/-in), Ratzinger, L., Zaborsky, N. (Co-Autor/-in), Clemens, H., Neureiter, D. (Co-Autor/-in), Neumayer, B. (Co-Autor/-in), Beate, A.-S., Florian, S., Martin, V., Grundbichler, M. (Co-Autor/-in), Weiss, L. (Co-Autor/-in), Melchardt, T. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Egle, A. (Letztautor/-in), Dez. 2021, in: PANCREATOLOGY. 21, 8, S. 1466-1471 6 S.Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
9 Quellenangaben (Web of Science) -
Non-pegylated Liposomal Doxorubicin as Palliative Chemotherapy in pre-Treated Advanced Pancreatic Cancer: A Retrospective Analysis of Twenty-Eight Patients.
Schlick, K. (Erstautor/-in), Kiem, D. (Co-Autor/-in), Huemer, F. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in), Weiss, L. (Co-Autor/-in) & Greil, R. (Letztautor/-in), 2021, in: TECHNOLOGY IN CANCER RESEARCH & TREATMENT. 20, S. 15330338211042139Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
3 Quellenangaben (Web of Science) -
Olaratumab plus anthracyline in advanced/metastatic soft tissue sarcoma : Data of real-world utilization in Austria.
Seeber, A., Weiss, L. (Co-Autor/-in), Romeder, F., Szkandera, J., Kuehr, T., Kostner, S., Pichler, P., Jaeger, T., Kocher, F., Greil, R. (Co-Autor/-in) & Brodowicz, T., 2021, in: WIENER KLINISCHE WOCHENSCHRIFT. 133, 1-2, S. 21-25Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
3 Quellenangaben (Web of Science) -
Postoperative chemoradiotherapy with cisplatin is superior to radioimmunotherapy with cetuximab and radiotherapy alone : Analysis of the Austrian head and neck cancer registry of the AGMT.
Magnes, T. (Erstautor/-in), Wagner, S. (Co-Autor/-in), Melchardt, T. (Co-Autor/-in), Weiss, L. (Co-Autor/-in), Rinnerthaler, G. (Co-Autor/-in), Huemer, F. (Co-Autor/-in), Kopp, M. (Co-Autor/-in), Gampenrieder, S. P. (Co-Autor/-in), Mayrbäurl, B., Füreder, T., Lenger, D., Andel, J., Egle, A. (Co-Autor/-in) & Greil, R. (Letztautor/-in), 2021, in: WIENER KLINISCHE WOCHENSCHRIFT. 133, 21-22, S. 1136Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
4 Quellenangaben (Web of Science) -
Spatial Heterogeneity in Large Resected Diffuse Large B-Cell Lymphoma Bulks Analysed by Massively Parallel Sequencing of Multiple Synchronous Biopsies.
Magnes, T. (Erstautor/-in), Wagner, S. (Co-Autor/-in), Thorner, A. R., Neureiter, D. (Co-Autor/-in), Klieser, E. (Co-Autor/-in), Rinnerthaler, G. (Co-Autor/-in), Weiss, L. (Co-Autor/-in), Huemer, F. (Co-Autor/-in), Schlick, K. (Co-Autor/-in), Zaborsky, N. (Co-Autor/-in), Steiner, M. (Co-Autor/-in), Greil, R. (Co-Autor/-in), Egle, A. (Co-Autor/-in) & Melchardt, T. (Letztautor/-in), 2021, in: Cancers. 13, 4Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
6 Quellenangaben (Web of Science) -
2020
Evaluation of circulating cell-free DNA as a molecular monitoring tool in patients with metastatic cancer
Hufnagl, C. (Erstautor/-in), Leisch, M. (Erstautor/-in), Weiss, L. (Co-Autor/-in), Melchardt, T. (Co-Autor/-in), Moik, M. (Co-Autor/-in), Asslaber, D. (Co-Autor/-in), Roland, G., Steininger, P. (Co-Autor/-in), Meissnitzer, T., Neureiter, D. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Egle, A. (Letztautor/-in), Feb. 2020, in: Oncology Letters. 19, 2, S. 1551-1558 8 S.Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
10 Quellenangaben (Web of Science) -
Hospitalizations and Clinical Outcome in Metastatic Colorectal Cancer During Regorafenib or TAS-102 Therapy.
Huemer, F. (Erstautor/-in), Piringer, G., Schlintl, V., Hackl, H., Rinnerthaler, G. (Co-Autor/-in), Thaler, J., Greil, R. (Co-Autor/-in) & Weiss, L. (Letztautor/-in), 2020, in: Cancers. 12, 10Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
4 Quellenangaben (Web of Science) -
Impact of PD-L1 Scores and Changes on Clinical Outcome in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiotherapy.
Huemer, F. (Erstautor/-in), Klieser, E. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in), Schlintl, V., Rinnerthaler, G. (Co-Autor/-in), Pagès, F., Kirilovsky, A., El Sissy, C., Iglseder, W. (Co-Autor/-in), Singhartinger, F. (Co-Autor/-in), Jäger, T. (Co-Autor/-in), Dinnewitzer, A. (Co-Autor/-in), Zaborsky, N. (Co-Autor/-in), Steiner, M. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Weiss, L. (Letztautor/-in), 2020, in: Journal of Clinical Medicine. 9, 9Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
12 Quellenangaben (Web of Science) -
Local and Central Evaluation of HER2 Positivity and Clinical Outcome in Advanced Gastric and Gastroesophageal Cancer-Results from the AGMT GASTRIC-5 Registry.
Huemer, F. (Erstautor/-in), Weiss, L. (Erstautor/-in), Regitnig, P., Winder, T., Hartmann, B., Thaler, J., Piringer, G., Schmitt, C. A., Eisterer, W., Gänzer, H., Wüstner, A., Andel, J., Jagdt, B., Ulmer, H., Greil, R. (Letztautor/-in) & Wöll, E., 2020, in: Journal of Clinical Medicine. 9, 4Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
12 Quellenangaben (Web of Science) -
Risks and Benefits of Glioblastoma Resection in Older Adults: A Retrospective Austrian Multicenter Study.
Schwartz, C. (Erstautor/-in), Romagna, A. (Co-Autor/-in), Stefanits, H., Zimmermann, G. J. (Co-Autor/-in), Ladisich, B. (Co-Autor/-in), Geiger, P., Rechberger, J., Winkler, S., Weiss, L. (Co-Autor/-in), Fastner, G. (Co-Autor/-in), Trinka, E. (Co-Autor/-in), Weis, S., Spiegl-Kreinecker, S., Steinbacher, J. (Co-Autor/-in), McCoy, M. R. (Co-Autor/-in), Johannes, T., Gruber, A., Rezai Jahromi, B., Niemelä, M. & Winkler, P. A. (Co-Autor/-in) &1 mehr, , 2020, in: World Neurosurgery. 133, S. e583-e591Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
11 Quellenangaben (Web of Science) -
2019
Baseline Absolute Lymphocyte Count and ECOG Performance Score Are Associated with Survival in Advanced Non-Small Cell Lung Cancer Undergoing PD-1/PD-L1 Blockade
Huemer, F. (Erstautor/-in), Lang, D., Westphal, T. (Co-Autor/-in), Gampenrieder, S. P. (Co-Autor/-in), Hutarew, G. (Co-Autor/-in), Weiss, L. (Co-Autor/-in), Hackl, H., Lamprecht, B., Rinnerthaler, G. (Letztautor/-in) & Greil, R. (Letztautor/-in), 10 Juli 2019, in: Journal of Clinical Medicine. 8, 7Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
43 Quellenangaben (Web of Science) -
C-Reactive Protein and Neutrophil/Lymphocytes Ratio: Prognostic Indicator for Doubling overall survival Prediction in Pancreatic Cancer Patients
Schlick, K. (Erstautor/-in), Magnes, T. (Co-Autor/-in), Huemer, F. (Co-Autor/-in), Ratzinger, L., Weiss, L. (Co-Autor/-in), Pichler, M., Melchardt, T. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Egle, A. (Letztautor/-in), 25 Okt. 2019, in: Journal of Clinical Medicine. 8, 11Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
15 Quellenangaben (Web of Science) -
Pharmacokinetics of liposomal curcumin (Lipocurc™) infusion: effect of co-medication in cancer patients and comparison with healthy individuals
Bolger, G. T., Licollari, A., Tan, A., Greil, R. (Co-Autor/-in), Vcelar, B., Greil-Ressler, S. (Co-Autor/-in), Weiss, L. (Co-Autor/-in), Schönlieb, C. (Co-Autor/-in), Magnes, T. (Co-Autor/-in), Radl, B. (Co-Autor/-in), Majeed, M. & Sordillo, P. P., Feb. 2019, in: CANCER CHEMOTHERAPY AND PHARMACOLOGY . 83, 2, S. 265-275 11 S.Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
22 Quellenangaben (Web of Science) -
Regorafenib Is Associated With Increased Skeletal Muscle Loss Compared to TAS-102 in Metastatic Colorectal Cancer.
Huemer, F. (Erstautor/-in), Schlintl, V., Hecht, S. (Co-Autor/-in), Hackl, H., Melchardt, T. (Co-Autor/-in), Rinnerthaler, G. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Weiss, L. (Letztautor/-in), 2019, in: CLINICAL COLORECTAL CANCER. 18, 2, S. 159-166.e3Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
20 Quellenangaben (Web of Science) -
Rituximab maintenance overcomes the negative prognostic factor of obesity in CLL: Subgroup analysis of the international randomized AGMT CLL-8a mabtenance trial.
Egle, A. (Erstautor/-in), Melchardt, T. (Erstautor/-in), Obrtlíková, P., Smolej, L., Kozák, T., Steurer, M., Andel, J., Burgstaller, S., Mikušková, E., Gercheva, L., Nösslinger, T., Papajík, T., Ladická, M., Girschikofsky, M., Hrubiško, M., Jäger, U., Voskova, D., Pecherstorfer, M., Králiková, E. & Burcoveanu, C. &17 mehr, , 2019, in: CANCER MEDICINE. 8, 4, S. 1405Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
7 Quellenangaben (Web of Science) -
2018
A phase 1 dose-escalation study on the safety, tolerability and activity of liposomal curcumin (Lipocurc™) in patients with locally advanced or metastatic cancer
Greil, R. (Erstautor/-in), Greil-Ressler, S. (Co-Autor/-in), Weiss, L. (Co-Autor/-in), Schönlieb, C. (Co-Autor/-in), Magnes, T. (Co-Autor/-in), Radl, B. (Co-Autor/-in), Bolger, G. T., Vcelar, B. & Sordillo, P. P., Okt. 2018, in: CANCER CHEMOTHERAPY AND PHARMACOLOGY . 82, 4, S. 695-706 12 S.Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
85 Quellenangaben (Web of Science) -
Clonal evolution and heterogeneity in metastatic head and neck cancer-An analysis of the Austrian Study Group of Medical Tumour Therapy study group
Melchardt, T. (Erstautor/-in), Magnes, T. (Co-Autor/-in), Hufnagl, C. (Co-Autor/-in), Thorner, A. R., Ducar, M., Neureiter, D. (Co-Autor/-in), Tränkenschuh, W., Klieser, E. (Co-Autor/-in), Gaggl, A. (Co-Autor/-in), Rösch, S. (Co-Autor/-in), Rasp, G. (Co-Autor/-in), Hartmann, T. (Co-Autor/-in), Pleyer, L. (Co-Autor/-in), Rinnerthaler, G. (Co-Autor/-in), Weiss, L. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Egle, A. (Letztautor/-in), Apr. 2018, in: EUROPEAN JOURNAL OF CANCER . 93, S. 69-78 10 S.Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
28 Quellenangaben (Web of Science) -
Establishment and validation of a novel risk model for estimating time to first treatment in 120 patients with chronic myelomonocytic leukaemia
Huemer, F. (Erstautor/-in), Weiss, L. (Erstautor/-in), Faber, V. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in), Egle, A. (Co-Autor/-in), Geissler, K., Voskova, D., Zebisch, A., Burgstaller, S., Pichler, A., Stauder, R., Sperr, W., Lang, A., Pfeilstöcker, M., Machherndl-Spandl, S., Stampfl, M., Greil, R. (Co-Autor/-in) & Pleyer, L. (Letztautor/-in), Feb. 2018, in: WIENER KLINISCHE WOCHENSCHRIFT. 130, 3-4, S. 115-125 11 S.Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
1 Quellenangabe (Web of Science) -
Fludarabine and rituximab with escalating doses of lenalidomide followed by lenalidomide/rituximab maintenance in previously untreated chronic lymphocytic leukaemia (CLL): the REVLIRIT CLL-5 AGMT phase I/II study.
Egle, A. (Erstautor/-in), Steurer, M., Melchardt, T. (Co-Autor/-in), Weiss, L. (Co-Autor/-in), Gassner, F. J. (Co-Autor/-in), Zaborsky, N. (Co-Autor/-in), Geisberger, R. (Co-Autor/-in), Catakovic, K. (Co-Autor/-in), Hartmann, T. (Co-Autor/-in), Pleyer, L. (Co-Autor/-in), Voskova, D., Thaler, J., Lang, A., Girschikofsky, M., Petzer, A. & Greil, R. (Letztautor/-in), 2018, in: ANNALS OF HEMATOLOGY . 97, 10, S. 1825-1839Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
11 Quellenangaben (Web of Science) -
Impact of antibiotic treatment on immune-checkpoint blockade efficacy in advanced non-squamous non-small cell lung cancer.
Huemer, F. (Erstautor/-in), Rinnerthaler, G. (Erstautor/-in), Westphal, T. (Co-Autor/-in), Hackl, H., Hutarew, G. (Co-Autor/-in), Gampenrieder, S. P. (Co-Autor/-in), Weiss, L. (Co-Autor/-in) & Greil, R. (Letztautor/-in), 2018, in: Oncotarget. 9, 23, S. 16520Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
-
Novel models for prediction of benefit and toxicity with FOLFIRINOX treatment of pancreatic cancer using clinically available parameters.
Schlick, K. (Erstautor/-in), Magnes, T. (Co-Autor/-in), Ratzinger, L., Jaud, B., Weiss, L. (Co-Autor/-in), Melchardt, T. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Egle, A. (Letztautor/-in), 2018, in: PLOS ONE. 13, 11, S. e0206688Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
12 Quellenangaben (Web of Science) -
Sidedness and TP53 mutations impact OS in anti-EGFR but not anti-VEGF treated mCRC - an analysis of the KRAS registry of the AGMT (Arbeitsgemeinschaft Medikamentöse Tumortherapie).
Huemer, F. (Erstautor/-in), Thaler, J., Piringer, G., Hackl, H., Pleyer, L. (Co-Autor/-in), Hufnagl, C. (Co-Autor/-in), Weiss, L. (Letztautor/-in) & Greil, R. (Letztautor/-in), 2018, in: BMC CANCER. 18, 1, S. 11Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
13 Quellenangaben (Web of Science) -
The influence of FCGR2A and FCGR3A polymorphisms on the survival of patients with recurrent or metastatic squamous cell head and neck cancer treated with cetuximab.
Magnes, T. (Erstautor/-in), Melchardt, T. (Erstautor/-in), Hufnagl, C. (Co-Autor/-in), Weiss, L. (Co-Autor/-in), Mittermair, C., Neureiter, D. (Co-Autor/-in), Klieser, E. (Co-Autor/-in), Rinnerthaler, G. (Co-Autor/-in), Roesch, S. (Co-Autor/-in), Gaggl, A. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Egle, A. (Letztautor/-in), 2018, in: PHARMACOGENOMICS J. 18, 3, S. 479Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
21 Quellenangaben (Web of Science) -
2017
Influence of body mass index on survival in indolent and mantle cell lymphomas: analysis of the StiL NHL1 trial
Weiss, L. (Erstautor/-in), Melchardt, T. (Co-Autor/-in), Egle, A. (Co-Autor/-in), Hopfinger, G. (Co-Autor/-in), Hackl, H., Greil, R. (Co-Autor/-in), Barth, J. & Rummel, M., Juli 2017, in: ANNALS OF HEMATOLOGY . 96, 7, S. 1155-1162 8 S.Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
4 Quellenangaben (Web of Science) -
Oxaliplatin/Irinotecan/Bevacizumab Followed by Docetaxel/Bevacizumab in Inoperable Locally Advanced or Metastatic Gastric Cancer Patients - AGMT_GASTRIC-3.
Wöll, E., Thaler, J., Keil, F., Gruenberger, B., Hejna, M., Eisterer, W., Fridrik, M. A., Ulmer, H., Trommet, V., Huemer, F. (Co-Autor/-in), Weiss, L. (Co-Autor/-in) & Greil, R. (Letztautor/-in), 2017, in: ANTICANCER RESEARCH . 37, 10, S. 5553-5558Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
9 Quellenangaben (Web of Science) -
Prognostic score in patients with recurrent or metastatic carcinoma of the head and neck treated with cetuximab and chemotherapy.
Magnes, T. (Erstautor/-in), Melchardt, T. (Erstautor/-in), Weiss, L. (Co-Autor/-in), Mittermair, C., Neureiter, D. (Co-Autor/-in), Klieser, E. (Co-Autor/-in), Gampenrieder, S. P. (Co-Autor/-in), Moser, G. (Co-Autor/-in), Gaggl, A. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Egle, A. (Letztautor/-in), 2017, in: PLOS ONE. 12, 7, S. e0180995Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
13 Quellenangaben (Web of Science) -
Red blood cell alloimmunization in 184 patients with myeloid neoplasms treated with azacitidine - A retrospective single center experience.
Leisch, M. (Erstautor/-in), Weiss, L. (Co-Autor/-in), Lindlbauer, N., Jungbauer, C., Egle, A. (Co-Autor/-in), Rohde, E. (Co-Autor/-in), Greil, R. (Co-Autor/-in), Grabmer, C. (Letztautor/-in) & Pleyer, L. (Letztautor/-in), 2017, in: LEUKEMIA RESEARCH . 59, S. 12-19Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
10 Quellenangaben (Web of Science) -
2016
Clonal evolution in relapsed and refractory diffuse large B-cell lymphoma is characterized by high dynamics of subclones
Melchardt, T. (Erstautor/-in), Hufnagl, C. (Erstautor/-in), Weinstock, D. M., Kopp, N., Neureiter, D. (Co-Autor/-in), Tränkenschuh, W. (Co-Autor/-in), Hackl, H., Weiss, L. (Co-Autor/-in), Rinnerthaler, G. (Co-Autor/-in), Hartmann, T. (Co-Autor/-in), Greil, R. (Co-Autor/-in), Weigert, O. & Egle, A. (Letztautor/-in), 9 Aug. 2016, in: Oncotarget. 7, 32, S. 51494-51502 9 S.Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
37 Quellenangaben (Web of Science) -
NCCN-IPI score-independent prognostic potential of pretreatment uric acid levels for clinical outcome of diffuse large B-cell lymphoma patients.
Prochazka, K. T., Melchardt, T. (Co-Autor/-in), Posch, F., Schlick, K. (Co-Autor/-in), Deutsch, A., Beham-Schmid, C., Weiss, L. (Co-Autor/-in), Gary, T., Neureiter, D. (Co-Autor/-in), Klieser, E. (Co-Autor/-in), Greil, R. (Co-Autor/-in), Neumeister, P., Egle, A. (Co-Autor/-in) & Pichler, M., 2016, in: BRITISH JOURNAL OF CANCER . 115, 10, S. 1264-1272Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
29 Quellenangaben (Web of Science) -
The clinical significance of fibrinogen plasma levels in patients with diffuse large B cell lymphoma.
Troppan, K. T., Melchardt, T. (Erstautor/-in), Wenzl, K., Schlick, K. (Co-Autor/-in), Deutsch, A., Bullock, M. D., Reitz, D., Beham-Schmid, C., Weiss, L. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in), Tränkenschuh, W. (Co-Autor/-in), Greil, R. (Co-Autor/-in), Neumeister, P., Egle, A. (Co-Autor/-in) & Pichler, M., 2016, in: JOURNAL OF CLINICAL PATHOLOGY . 69, 4, S. 326-330Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
18 Quellenangaben (Web of Science) -
2015
Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial
Gnant, M., Pfeiler, G., Dubsky, P. C., Hubalek, M., Greil, R. (Co-Autor/-in), Jakesz, R., Wette, V., Balic, M., Haslbauer, F., Melbinger, E., Bjelic-Radisic, V., Artner-Matuschek, S., Fitzal, F., Marth, C., Sevelda, P., Mlineritsch, B. (Co-Autor/-in), Steger, G. G., Manfreda, D., Exner, R. & Egle, D. &7 mehr, , 1 Aug. 2015, in: LANCET . 386, 9992, S. 433-43 11 S.Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
387 Quellenangaben (Web of Science) -
A modified scoring of the NCCN-IPI is more accurate in the elderly and is improved by albumin and β2 -microglobulin.
Melchardt, T. (Erstautor/-in), Troppan, K., Weiss, L. (Co-Autor/-in), Hufnagl, C. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in), Tränkenschuh, W. (Co-Autor/-in), Hopfinger, G. (Co-Autor/-in), Magnes, T. (Co-Autor/-in), Deutsch, A., Neumeister, P., Hackl, H., Greil, R. (Co-Autor/-in), Pichler, M. & Egle, A. (Letztautor/-in), 2015, in: BRITISH JOURNAL OF HAEMATOLOGY . 168, 2, S. 239-245Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
66 Quellenangaben (Web of Science) -
CYP39A1 polymorphism is associated with toxicity during intensive induction chemotherapy in patients with advanced head and neck cancer
Melchardt, T. (Erstautor/-in), Hufnagl, C. (Erstautor/-in), Magnes, T. (Co-Autor/-in), Weiss, L. (Co-Autor/-in), Hutarew, G. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in), Schlattau, A. (Co-Autor/-in), Moser, G. (Co-Autor/-in), Gaggl, A. (Co-Autor/-in), Tränkenschuh, W. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Egle, A. (Letztautor/-in), 16 Okt. 2015, in: BMC CANCER. 15, S. 725Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
12 Quellenangaben (Web of Science) -
Independent Prognostic Value of Serum Markers in Diffuse Large B-Cell Lymphoma in the Era of the NCCN-IPI.
Melchardt, T. (Erstautor/-in), Troppan, K., Weiss, L. (Co-Autor/-in), Hufnagl, C. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in), Tränkenschuh, W. (Co-Autor/-in), Schlick, K. (Co-Autor/-in), Huemer, F. (Co-Autor/-in), Deutsch, A., Neumeister, P., Greil, R. (Co-Autor/-in), Pichler, M. & Egle, A. (Letztautor/-in), 2015, in: JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK. 13, 12, S. 1501-1508Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
30 Quellenangaben (Web of Science) -
The significance of pretreatment anemia in the era of R-IPI and NCCN-IPI prognostic risk assessment tools: a dual-center study in diffuse large B-cell lymphoma patients.
Troppan, K. T., Melchardt, T. (Erstautor/-in), Deutsch, A., Schlick, K. (Co-Autor/-in), Stojakovic, T., Bullock, M. D., Reitz, D., Beham-Schmid, C., Weiss, L. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in), Wenzl, K., Greil, R. (Co-Autor/-in), Neumeister, P., Egle, A. (Co-Autor/-in) & Pichler, M., 2015, in: EUROPEAN JOURNAL OF HAEMATOLOGY . 95, 6, S. 538-544Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
27 Quellenangaben (Web of Science) -
Treatment of aggressive B-cell lymphoma in elderly patients: influence of single nucleotide polymorphisms affecting pharmacodynamics of chemotherapeutics.
Melchardt, T. (Erstautor/-in), Weiss, L. (Co-Autor/-in), Hufnagl, C. (Co-Autor/-in), Neureiter, D. (Co-Autor/-in), Kemmerling, R., Morre, P. (Co-Autor/-in), Boekstegers, A., Hopfinger, G. (Co-Autor/-in), Auberger, J. (Co-Autor/-in), Steinkirchner, S. (Co-Autor/-in), Pleyer, L. (Co-Autor/-in), Greil, R. (Co-Autor/-in) & Egle, A. (Letztautor/-in), 2015, in: LEUKEMIA & LYMPHOMA . 56, 2, S. 353-360Publikation: Beitrag in Fachzeitschrift › Originalarbeit › Begutachtung
3 Quellenangaben (Web of Science)